资讯 | 美股财报季到来。百威英博取消香港上市。中国重要经济数据今日公布

wechat omage

美股

北京时间7月13日凌晨,美股周五收高,三大股指均创盘中与收盘历史最高纪录,标普500指数史上首次收在3000点关口上方。美联储主席鲍威尔的国会证词提高了市场对美联储在7月底降息的预期。市场同时还在关注美国债务上限问题。截止收盘,道指涨243.95点,或0.9%,报27332.03点;标普500指数涨13.86点,或0.46%,报3013.77点;纳指涨48.10点,或0.59%,报8244.14点。周五盘中,道指最高上涨至27333.79点,标普500指数上涨至3013.92点,纳指上涨至8245.66点,均刷新了各自的盘中最高纪录。美联储主席杰罗姆-鲍威尔(Jerome Powell)本周发表的鸽派言论提高了市场的风险投资偏好。鲍威尔周四在美国参议院银行业委员会讲话称,美国经济“状况良好”,但还没有从5月份国际商贸紧张局势恶化时遭受的“信心打击”中完全复苏。他称美国的货币政策可能过于紧张,美联储仍有降息空间。

市场认为,鲍威尔周四的讲话及其周三在国会众议院金融委员会的证词,确认了市场关于美联储将在7月30-31日会议上至少降息25个基点、并且有可能在年底继续降息的预期。

美国联邦政府的债务上限问题重新浮现。美国众议院议长南希-佩洛西表示,国会应该在本月采取行动提高债务上限,但目前尚不清楚的是,在众议院7月26日开始为期6周的休会之前,国会和白宫能否达成协议。

美国国会领导人越来越多地认识到,如果新的非官方估计数字正确的话,那么等到9月份才提高债务上限将会导致违约风险增大。
美国共和党、民主党和特朗普政府官员本周加大了对话力度,并且各方都表示将达成协议。美国财政部尚未向国会提供最新的官方估计,以说明在违约前还有多少时间。在休会之后,议员们要到9月9日才会返回华盛顿。

美国财长努钦也在周五呼吁:国会应在8月休会前提高债务上限。美国上市公司财报季将从本周正式开启,一些大型银行将率先公布业绩。

宏观基本面:美国经济数据面,受商贸服务推动,衡量美国核心生产者价格水平的一项指标6月份涨幅超过预期,表明通胀水平可能开始趋于稳定。美国劳工部周五公布的数据显示,6月份扣除食品和能源的生产者价格指数(PPI)同比增长2.3%,与5月同比涨幅一致,超过2.1%的预估中值。整体PPI连续第二个月环比上涨0.1%,预期为持平。

焦点股关注:波音(BA)737MAX项目更换负责人。波音总裁表示,波音737MAX项目负责人埃里克-林德布拉德离职,他的职位由马克-詹克斯接替。波音收高1.5%。特斯拉(TSLA)近期以Autopilot技术的源代码被窃为由,对其前员工、现小鹏汽车员工曹光植提起诉讼。特斯拉收高2.7%。福特汽车(F)收高2.9%。有消息称大众将向福特支持的自动驾驶公司注资26亿美元。Illumina(ILMN)收盘重挫16.1%。该公司在周四收盘后更新了第二财季业绩展望,称预计营收将比原先预期值低5000万美元,调整后的营收将低于分析师预期。塑料制品生产商Milacron Holdings(MCRN)收盘大涨23.8%,该公司与Hillenbrand(HI)宣布,Hillenbrand将以价值20亿美元的现金加股票方式收购前者,报价较其周四收盘市值溢价率为33.5%。埃森哲(ACN)周四收盘后宣布,公司董事会已任命Julie Sweet为新任CEO,其临时CEO David Rowland被任命为执行董事长。埃森哲收高0.8%。

 

   

港股

北京时间7月12日,美国减息预期持续升温,推动道指和标普500再创新高,道指首次突破27000点。周五早盘,恒指低开高走,午后恒指涨幅收窄。截至收盘,港股恒生指数涨0.14%,报28471.62点;国企指数涨0.04%,报10788.34点;红筹指数跌0.83%,报4456.47点。

热点板块:中国人寿涨1.81%,报20.2港元,领涨蓝筹。美国减息预期持续升温,内服股集体走高。新城发展涨7.98%,绿城中国涨4.2%,万科涨0.48%。安踏周四被浑水狙击第三弹,股价收涨1%,周五股价高开2.34%,收盘涨0.29%。大和表示:浑水对安踏最新两份报告建立在误导性的信息基础之上;维持对安踏的买入评级和63.60港元目标价。目前,浑水已经针对安踏发布三部分沽空报告,浑水表示:安踏秘密控制了其一级经销商,以提高其利润率;浑水认为安踏内部人士欺骗外部投资者,并以投资者为代价获取利益;浑水表示:投资者不能相信安踏斐乐店的数量。广汇宝信再跌约10%,势将录得11连跌,月内股价腰斩,跌幅高达52.4%。据中汽协公布的最新产销数据显示,2019年6月份,我国汽车产销同比降幅有所收窄,产销量分别为189.5万辆和205.6万辆,环比增幅为2.5%和7.5%,较去年同期下跌17.3%和9.6%。中国全通大涨61%,宣布与认购人VCB Asia Telco Fund签署谅解备忘录,认购人拟将以现金认购公司新股,占扩大已发行股本超过30%.认购人届时可能申请清洗豁免。

百威英博取消香港上市

啤酒商百威英博(Anheuser-Busch InBev)(ABI.BR)周五表示,将不再推进其亚太业务–百威亚太控股有限公司(Budweiser Brewing Company APAC)在香港上市的计划,本来这将成为2019年全球最大规模的首次公开招股(IPO)。这次IPO被认为是未来大规模发股的试金石。百威英博是全球最大的啤酒商,原本打算通过本次IPO筹资最多98亿美元,用于减轻公司沉重的债务负担。这次IPO取消对港交所而言也是一次重大挫折,港交所原本希望通过百威英博的上市能够帮助吸引其它国际性大公司前来。百威英博表示,取消上市的决定缘于“多方面因素,其中包括现行市场状况”。该公司股价在盘后交易中下跌约4%。百威亚太在中美贸易战的背景下取消香港IPO计划,为其它的香港大型IPO投下阴影。

 

中国A股

北京时间7月12日,早盘三大股指开盘涨跌不一,开盘之后在化工等板块的带动下,三大股指全线飘红,随后冲高回落,临近午盘银行股异动,带领指数再度走强,午后两市整体维持窄幅震荡,大金融板块护盘。整体来看,市场情绪依旧较弱,成交量继续萎缩,北向资金流入约17亿元。截止收盘,沪指报2930.55点,涨0.44%,深成指报9213.38点,涨0.66%。

热点板块:化工板块全天领涨两市,截止收盘,六国化工等多股涨停,多氟多、亿利洁能、氯碱化工、云天化纷纷大涨。消息面上一方面,国内环保趋严,磷化工主产省份开始停工自查,导致黄磷价格暴涨;另一方面,日本加强对韩国半导体生产关键性化工原料出口管理生效,韩国进而谋求中国相关产品替代。保险板块表现强势,截止收盘,中国人寿大涨5%,中国太保、新华保险、中国保险、中国平安纷纷跟涨。国家统计局15日将公布上半年国内生产总值(GDP)、就业、收入、消费等重磅数据。这些关键指标表现如何,中国经济能否延续稳中有进态势,尤其受到外界关注。

 
如果有想了解更多全球股市资讯,请关注微信公众共 “辉立资本新加坡” (SGPSPL)

同时提供在线免费开设股票账户,一个账户轻松交易美股,港股,新加坡股
 

来源:东方财富网,新浪财经,同花顺,21世纪经济报道,彭博,华尔街见闻,辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com